Deleted Tweets From Scott Gottlieb, R-D.C.

FDA is committed to working with industry and stakeholders to help ensure that sunscreens are safe and effective for daily, life-long use. As the rulemaking proceeds, OTC sunscreen products will continue to be available on the market for consumer use https://t.co/30fUVQ6Gf5

Message is clear: e-cigs may be a good alternative for currently addicted adult smokers to FULLY transition off cigarettes, but they have risks. Research suggests they can damage mucosa, including evidence we’ve seen at FDA. No child should be using them. https://t.co/1aqCmog89C

RT @berthacoombs: As the child of a heavy smoker who died of lung cancer and a social smoker who now suffers with COPD, I don’t wish the da… QT @SGottliebFDA: Message is clear: e-cigs may be a good alternative for currently addicted adult smokers to FULLY transition off cig… https://t.co/rfaMAtRqdh)

.⁦@SecAzar⁩ has been a strong advocate for sensible tobacco policies that advance ways to help adult smokers quit while protecting kids from tobacco. He is a committed champion for the #FDA’s public health mission and a great partner to the agency. https://t.co/7UpGRZERDJ

1,807 calls to poison control centers about herbal supplement kratom: https://t.co/wNy2HwF7xr

RT @SecAzar: There is no better example of an opportunity to achieve greater value in our healthcare system than kidney care. As… https://t.co/gXfvRgbd5z

RT @ABC: FDA puts more than a dozen U.S. stores on notice as part of the agency’s effort to limit youth access to e-cigarett… https://t.co/0J5mBain1M

Today #FDA released draft guidance to help food manufacturers further protect Americans from intentionally adulterated food products by clarifying FSMA’s requirements for mitigating risk from this type of adulteration. For more info, visit: https://t.co/qTZhY7AQdB https://t.co/hr0x3bHOf2

RT @FDATobacco: NYTS KEY FINDING: E-cigarette use surge led to uptick in overall tobacco use #YouthTobaccoUse Due to the increase… https://t.co/kL7p4r8slX

I’m coming up on @SquawkCNBC to discuss #FDA’s continuing steps to prevent illegal tobacco sales to minors; among other things, by targeting corporate store chains with a history of significant repeat violations and not just individual stores. https://t.co/Hd1IgnPIww

Truly grateful Ned to have worked with you on so many important endeavors and I’m inspired by your continued leadership and lifelong commitment to patients. You’re a great friend to the FDA and a committed partner to our shared public health goals. QT @NCIDirector: Scott has done a lot for cancer patients and all Americans. Bold leadership on tobacco control, generic drugs, nov… https://t.co/kv89d9tXD4)

Thank you @IvankaTrump for your support of our public health mission and our goals of advancing access to affordable medicines, tackling opioid addiction, protecting kids from tobacco, promoting innovation for patients and so much more. Serving in this role was the greatest honor QT @IvankaTrump: Thank you @SGottliebFDA for your tremendous service to our nation as FDA Commissioner. You have made an extraordi… https://t.co/YXmPGoyQa5)

RT @IvankaTrump: Thank you @SGottliebFDA for your tremendous service to our nation as FDA Commissioner. You have made an extraordi… https://t.co/YXmPGoyQa5

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA, on FDA’s steps on naming of biological medicines to balance competit… https://t.co/TjpgJWvpBZ

@RebeccaDRobbins @statnews Happy Anniversary

RT @mcipriano93: Historic Output Of Disease-Specific Guidances Is Among Gottlieb's Legacies At US FDA https://t.co/hIDZ6kSXHU

I’m looking forward to speaking at the Alexandria Summitt tonight to discuss the FDAs continuing efforts to advance nutrition strategy and food innovation and our policy roadmap for 2019.

RT @CliffordHudis: Always great to listen to inspired and inspiring leaders. Thank you @NCIDirector for leading with grace and focus. https… QT @ASCO: .@NCIDirector talks with @CliffordHudis about #bigdata, #clinicaltrials, & how to build the cancer research workfor… https://t.co/Z4rNbfkUN2)

#FDA is committed to reducing death and disease from tobacco, and ending youth use, until my last day at the agency - and then for all the decades thereafter. We have no more impactful tool to reduce mortality than our tool of tobacco product regulation. https://t.co/S8LTHTfObH

RT @SGottliebFDA: #FDA is committed to reducing death and disease from tobacco, and ending youth use, until my last day at the agency… https://t.co/4sYvI7rH7G

Co-developed by the Patient Affairs Staff @FDAPatientInfo and the medical product centers, the portal will route inquiries to the appropriate medical product center or office to ensure that they are received and responded to in an effective and efficient manner.

I’m excited that my vision for a single, central entry point for patients and caregivers to submit questions and meeting requests to the #FDA has come to fruition via our new web portal, “Request to Connect.” @FDAPatientInfo https://t.co/TUrmpQ277h

@angelicalavito @chrissyfarr @berthacoombs @BerkeleyJr This is bitter. I reject it. I thought my jokes were pretty good!

RT @steveusdin1: .@BioCentury’s exit interview w SGottliebFDA. His approach to promoting medical innovation, strategic communication… https://t.co/bH24j97shA

RT @tmprowell: From VERY humble beginnings--fellows actually carpooled from other states & slept in the FDA pkg lot �--the… https://t.co/9CWNlQJEWU

RT @aawayne: NEWS: Acting White House Chief of Staff Mick Mulvaney says President Trump backed outgoing FDA commish… https://t.co/31f7z19hXU

RT @SGottliebFDA: I’m excited that my vision for a single, central entry point for patients and caregivers to submit questions and me… https://t.co/bQR0aLirXO

RT @US_FDA: Did you know the #FDA has a role in keeping cosmetics safe? Check out this week’s #SundayTweetorial from @SGottliebFDA! https:/… QT @SGottliebFDA: Cosmetic products are sold to consumers and used as part of daily beauty and cleansing routines. In today’s #FDA… https://t.co/9w9mJXFtBj)

RT @FrankYiannasFDA: Food traceability becoming a national priority around the world. French President Macron calls on Europe to use new… https://t.co/zWlIXpGwhb

RT @SGottliebFDA: Cosmetic products are sold to consumers and used as part of daily beauty and cleansing routines. In today’s #FDA… https://t.co/9w9mJXFtBj

To inform our policymaking, #FDA advances a new survey of health professionals to gauge how promotional activities by drug makers influence provider perceptions related to abuse-deterrent formulations for opioid products. https://t.co/R9PHu52FLe

RT @FrankYiannasFDA: Industry can do much to advance food safety. Government can do a lot too. What’s clear to me, having been on both… https://t.co/BuIJujytun

RT @FDATobacco: It’s Brain Awareness Week! � During #BrainWeek discover some facts about smoking and the brain. #FACT Smoking ca… https://t.co/pKNlfJ4d9O

RT @US_FDA: Smoking can block blood flow to the brain and can lead to stroke which can cause brain damage and death. During… https://t.co/P9OL5U9QkU

RT @LGMAnews: .@US_FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner @FrankYiannasFDA, emphasized the need for additi… https://t.co/yYZZU1Fm4T

We’ve posted the agenda for our March 25-26 meeting on breast implants. We look forward to thoughtful engagement with patients, scientists, doctors and manufacturers about breast implants and the growing science regarding their risks along with benefits. https://t.co/2y8ro8G1fw https://t.co/lnD1gGQDUQ

Today, #FDA requested new funding in the President’s FY2020 budget to continue to advance robust reg. framework for e-cigarettes oversight, prevent youth access/initiation & harness innovation to advance safety of food, compounded drugs, U.S. blood supply https://t.co/KCBAcrmYxr

We’re grateful for the Administration’s support of #FDA’s initiatives for urgent public health priorities and believe these investments in our core consumer protection mission will ultimately lead both to better health outcomes for American families and to a more vibrant economy

RT @FDAPatientinfo: Attending the Patient Advocacy Summit today in Philadelphia? Our Director, Andrea Furia-Helms, will be discussing… https://t.co/QCzk3JXxUQ

RT @FDAOMH: Vaccines are safe, effective and one of our greatest public health achievements. Get the facts on vaccines at the M… https://t.co/twSopXiZ2F

RT @FDASpox: Statement from @SGottliebFDA on request for new #FDA funding to continue to advance a robust reg. framework for ove… https://t.co/C84YwG94p2

These substantial new resources in the @POTUS Budget will help #FDA continue to exert aggressive oversight to stop youth use of e-cigs, while implementing an appropriate regulatory framework to oversee the adult use of these products. https://t.co/8TVV2NPL1B

I’m delighted by the announcement from @SecAzar that @NCIDirector will serve as acting commissioner of #FDA. Ned is a friend to FDA, a great public health champion, a dedicated physician, and will be warmly welcomed into his new role. FDA will benefit greatly from his leadership.

RT @SeanKhozin: The spirit of #innovation and collaboration that has been one of the defining features of @NCIDirector’s tenure to date wil… QT @SGottliebFDA: I’m delighted by the announcement from @SecAzar that @NCIDirector will serve as acting commissioner of #FDA. Ned is… https://t.co/5sjMIbyeT1)

RT @FDA_Drug_Info: #FDA releases four draft guidances and one final guidance to encourage broadening of patient participation in cance… https://t.co/W2CP1JkKGD

RT @tmprowell: Four new draft Guidances & one final Guidance from #FDAOncology on eligibility criteria for #oncology… https://t.co/irLQXVhUhg

RT @FDASpox: Today, @US_FDA qualified a biomarker medical device development tool. The tool provides a standard way for doctors… https://t.co/BgTq0RhDhw

We hope today’s approval of a new generic will help reduce the valsartan shortage, and we remain committed to implementing measures to prevent the formation of impurities during drug manufacturing processes for existing and future valsartan products. https://t.co/uh4NcpjX3p

RT @FDASpox: Read @SGottliebFDA’s statement on advancing new policies aimed at preventing youth access to, and appeal of, flavor… https://t.co/iSisP3japa

RT @SGottliebFDA: The #FDA will not allow a generation of children to become addicted to nicotine. This effort will carry on. This is… https://t.co/Nrlko72P6l

FDA is committed to working with industry and stakeholders to help ensure that sunscreens are safe and effective for daily, life-long use. As the rulemaking proceeds, OTC sunscreen products will continue to be available on the market for consumer use https://t.co/30fUVQ6Gf5

Message is clear: e-cigs may be a good alternative for currently addicted adult smokers to FULLY transition off cigarettes, but they have risks. Research suggests they can damage mucosa, including evidence we’ve seen at FDA. No child should be using them. https://t.co/1aqCmog89C

RT @berthacoombs: As the child of a heavy smoker who died of lung cancer and a social smoker who now suffers with COPD, I don’t wish the da… QT @SGottliebFDA: Message is clear: e-cigs may be a good alternative for currently addicted adult smokers to FULLY transition off cig… https://t.co/rfaMAtRqdh)

.⁦@SecAzar⁩ has been a strong advocate for sensible tobacco policies that advance ways to help adult smokers quit while protecting kids from tobacco. He is a committed champion for the #FDA’s public health mission and a great partner to the agency. https://t.co/7UpGRZERDJ

1,807 calls to poison control centers about herbal supplement kratom: https://t.co/wNy2HwF7xr

RT @SecAzar: There is no better example of an opportunity to achieve greater value in our healthcare system than kidney care. As… https://t.co/gXfvRgbd5z

RT @ABC: FDA puts more than a dozen U.S. stores on notice as part of the agency’s effort to limit youth access to e-cigarett… https://t.co/0J5mBain1M

Today #FDA released draft guidance to help food manufacturers further protect Americans from intentionally adulterated food products by clarifying FSMA’s requirements for mitigating risk from this type of adulteration. For more info, visit: https://t.co/qTZhY7AQdB https://t.co/hr0x3bHOf2

RT @FDATobacco: NYTS KEY FINDING: E-cigarette use surge led to uptick in overall tobacco use #YouthTobaccoUse Due to the increase… https://t.co/kL7p4r8slX

I’m coming up on @SquawkCNBC to discuss #FDA’s continuing steps to prevent illegal tobacco sales to minors; among other things, by targeting corporate store chains with a history of significant repeat violations and not just individual stores. https://t.co/Hd1IgnPIww

Truly grateful Ned to have worked with you on so many important endeavors and I’m inspired by your continued leadership and lifelong commitment to patients. You’re a great friend to the FDA and a committed partner to our shared public health goals. QT @NCIDirector: Scott has done a lot for cancer patients and all Americans. Bold leadership on tobacco control, generic drugs, nov… https://t.co/kv89d9tXD4)

Thank you @IvankaTrump for your support of our public health mission and our goals of advancing access to affordable medicines, tackling opioid addiction, protecting kids from tobacco, promoting innovation for patients and so much more. Serving in this role was the greatest honor QT @IvankaTrump: Thank you @SGottliebFDA for your tremendous service to our nation as FDA Commissioner. You have made an extraordi… https://t.co/YXmPGoyQa5)

RT @IvankaTrump: Thank you @SGottliebFDA for your tremendous service to our nation as FDA Commissioner. You have made an extraordi… https://t.co/YXmPGoyQa5

RT @FDAMedia: Statement from FDA Commissioner @SGottliebFDA, on FDA’s steps on naming of biological medicines to balance competit… https://t.co/TjpgJWvpBZ

@RebeccaDRobbins @statnews Happy Anniversary

RT @mcipriano93: Historic Output Of Disease-Specific Guidances Is Among Gottlieb's Legacies At US FDA https://t.co/hIDZ6kSXHU

I’m looking forward to speaking at the Alexandria Summitt tonight to discuss the FDAs continuing efforts to advance nutrition strategy and food innovation and our policy roadmap for 2019.

RT @CliffordHudis: Always great to listen to inspired and inspiring leaders. Thank you @NCIDirector for leading with grace and focus. https… QT @ASCO: .@NCIDirector talks with @CliffordHudis about #bigdata, #clinicaltrials, & how to build the cancer research workfor… https://t.co/Z4rNbfkUN2)

#FDA is committed to reducing death and disease from tobacco, and ending youth use, until my last day at the agency - and then for all the decades thereafter. We have no more impactful tool to reduce mortality than our tool of tobacco product regulation. https://t.co/S8LTHTfObH

RT @SGottliebFDA: #FDA is committed to reducing death and disease from tobacco, and ending youth use, until my last day at the agency… https://t.co/4sYvI7rH7G

Co-developed by the Patient Affairs Staff @FDAPatientInfo and the medical product centers, the portal will route inquiries to the appropriate medical product center or office to ensure that they are received and responded to in an effective and efficient manner.

I’m excited that my vision for a single, central entry point for patients and caregivers to submit questions and meeting requests to the #FDA has come to fruition via our new web portal, “Request to Connect.” @FDAPatientInfo https://t.co/TUrmpQ277h

@angelicalavito @chrissyfarr @berthacoombs @BerkeleyJr This is bitter. I reject it. I thought my jokes were pretty good!

RT @steveusdin1: .@BioCentury’s exit interview w SGottliebFDA. His approach to promoting medical innovation, strategic communication… https://t.co/bH24j97shA

RT @tmprowell: From VERY humble beginnings--fellows actually carpooled from other states & slept in the FDA pkg lot �--the… https://t.co/9CWNlQJEWU

RT @aawayne: NEWS: Acting White House Chief of Staff Mick Mulvaney says President Trump backed outgoing FDA commish… https://t.co/31f7z19hXU

RT @SGottliebFDA: I’m excited that my vision for a single, central entry point for patients and caregivers to submit questions and me… https://t.co/bQR0aLirXO

RT @US_FDA: Did you know the #FDA has a role in keeping cosmetics safe? Check out this week’s #SundayTweetorial from @SGottliebFDA! https:/… QT @SGottliebFDA: Cosmetic products are sold to consumers and used as part of daily beauty and cleansing routines. In today’s #FDA… https://t.co/9w9mJXFtBj)

RT @FrankYiannasFDA: Food traceability becoming a national priority around the world. French President Macron calls on Europe to use new… https://t.co/zWlIXpGwhb

RT @SGottliebFDA: Cosmetic products are sold to consumers and used as part of daily beauty and cleansing routines. In today’s #FDA… https://t.co/9w9mJXFtBj

To inform our policymaking, #FDA advances a new survey of health professionals to gauge how promotional activities by drug makers influence provider perceptions related to abuse-deterrent formulations for opioid products. https://t.co/R9PHu52FLe

RT @FrankYiannasFDA: Industry can do much to advance food safety. Government can do a lot too. What’s clear to me, having been on both… https://t.co/BuIJujytun

RT @FDATobacco: It’s Brain Awareness Week! � During #BrainWeek discover some facts about smoking and the brain. #FACT Smoking ca… https://t.co/pKNlfJ4d9O

RT @US_FDA: Smoking can block blood flow to the brain and can lead to stroke which can cause brain damage and death. During… https://t.co/P9OL5U9QkU

RT @LGMAnews: .@US_FDA Commissioner Scott Gottlieb, M.D. and Deputy Commissioner @FrankYiannasFDA, emphasized the need for additi… https://t.co/yYZZU1Fm4T

We’ve posted the agenda for our March 25-26 meeting on breast implants. We look forward to thoughtful engagement with patients, scientists, doctors and manufacturers about breast implants and the growing science regarding their risks along with benefits. https://t.co/2y8ro8G1fw https://t.co/lnD1gGQDUQ

Today, #FDA requested new funding in the President’s FY2020 budget to continue to advance robust reg. framework for e-cigarettes oversight, prevent youth access/initiation & harness innovation to advance safety of food, compounded drugs, U.S. blood supply https://t.co/KCBAcrmYxr

We’re grateful for the Administration’s support of #FDA’s initiatives for urgent public health priorities and believe these investments in our core consumer protection mission will ultimately lead both to better health outcomes for American families and to a more vibrant economy

RT @FDAPatientinfo: Attending the Patient Advocacy Summit today in Philadelphia? Our Director, Andrea Furia-Helms, will be discussing… https://t.co/QCzk3JXxUQ

RT @FDAOMH: Vaccines are safe, effective and one of our greatest public health achievements. Get the facts on vaccines at the M… https://t.co/twSopXiZ2F

RT @FDASpox: Statement from @SGottliebFDA on request for new #FDA funding to continue to advance a robust reg. framework for ove… https://t.co/C84YwG94p2

These substantial new resources in the @POTUS Budget will help #FDA continue to exert aggressive oversight to stop youth use of e-cigs, while implementing an appropriate regulatory framework to oversee the adult use of these products. https://t.co/8TVV2NPL1B

I’m delighted by the announcement from @SecAzar that @NCIDirector will serve as acting commissioner of #FDA. Ned is a friend to FDA, a great public health champion, a dedicated physician, and will be warmly welcomed into his new role. FDA will benefit greatly from his leadership.

RT @SeanKhozin: The spirit of #innovation and collaboration that has been one of the defining features of @NCIDirector’s tenure to date wil… QT @SGottliebFDA: I’m delighted by the announcement from @SecAzar that @NCIDirector will serve as acting commissioner of #FDA. Ned is… https://t.co/5sjMIbyeT1)

RT @FDA_Drug_Info: #FDA releases four draft guidances and one final guidance to encourage broadening of patient participation in cance… https://t.co/W2CP1JkKGD

RT @tmprowell: Four new draft Guidances & one final Guidance from #FDAOncology on eligibility criteria for #oncology… https://t.co/irLQXVhUhg

RT @FDASpox: Today, @US_FDA qualified a biomarker medical device development tool. The tool provides a standard way for doctors… https://t.co/BgTq0RhDhw

We hope today’s approval of a new generic will help reduce the valsartan shortage, and we remain committed to implementing measures to prevent the formation of impurities during drug manufacturing processes for existing and future valsartan products. https://t.co/uh4NcpjX3p

RT @FDASpox: Read @SGottliebFDA’s statement on advancing new policies aimed at preventing youth access to, and appeal of, flavor… https://t.co/iSisP3japa

RT @SGottliebFDA: The #FDA will not allow a generation of children to become addicted to nicotine. This effort will carry on. This is… https://t.co/Nrlko72P6l